Clinical Trials on Type B Aortic Dissection in New Zealand

Total 847 results

W.L.Gore & Associates

Completed

Evaluation of the GORE Conformable TAG® Thoracic Endoprosthesis for Treatment of Acute Complicated Type B Aortic Dissection

Type B Aortic Dissection

United States
Bolton Medical

Active, not recruiting

Study of the RelayPro Thoracic Stent-Graft in Subjects With an Acute, Complicated Type B Aortic Dissection

Aortic Dissection Type B

United States
Duke University
The University of Texas Health Science Center, Houston; National Heart, Lung... and other collaborators

Recruiting

IMPRoving Outcomes in Vascular DisEase- Aortic Dissection (IMPROVE-AD)

Type B Aortic Dissection

United States
Medtronic Cardiovascular
NAMSA

Active, not recruiting

DISSECT-N Post Market Data Collection Registry (DISSECT-N)

Thoracic Aortic Dissection

United States, Korea, Republic of, Netherlands, Denmark, New Zealand, Thailand, Japan, Slovakia, Greece, Italy
Yale University

Completed

Point-of-Care Focused Cardiac Ultrasound in Assessing the Thoracic Aorta

Aortic Dissection | Aortic Aneurysm, Thoracic

United States
University of Calgary

Recruiting

Hemiarch vs Extended Arch in Type 1 Aortic Dissection (HEADSTART)

Aortic Dissection

Canada
Cook Research Incorporated

Approved for marketing

Zenith® Dissection Endovascular System in the Treatment of Patients With Aortic Dissections

Aortic Dissection

United States
Bolton Medical
Vascutek Ltd.

Completed

Thoraflex™ Hybrid IDE Study

Aortic Aneurysm | Aortic Dissection | Aortic Rupture

United States
Cook Group Incorporated

Completed

Zenith® Dissection Endovascular System (STABLE I)

Aortic Dissection

United States
Vascutek Ltd.
Bolton Medical

Recruiting

Thoraflex Hybrid and Relay Extension Post-Approval Study (EXTEND)

Thoracic Diseases | Aortic Aneurysm | Aortic Dissection | Thoracic Aortic Aneurysm | Thoracic Aortic Dissection

United States, Spain, Germany, Austria
Medtronic Cardiovascular
Medtronic

Completed

Study to Evaluate the Clinical Performance of the Valiant Thoracic Stent Graft With the Captivia Delivery System (Valiant Captivia) for the Treatment of Acute, Complicated Type B Aortic Dissections

Aortic Dissection

United States
JOTEC GmbH
MedPass International

Recruiting

A Study in Patients With Complicated Type B Aortic Dissection Treated With the E-nya Thoracic Stent Graft (CONFORM-TAD)

Vascular Diseases

Germany
Cook Research Incorporated

Completed

Zenith® Dissection Clinical Trial

Aortic Dissection

United States, Japan
Darren Schneider, M.D.

Recruiting

Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts

Aortic Aneurysm, Thoracic | Aortic Aneurysm, Thoracoabdominal | Aortic Dissection, Thoracoabdominal

United States
IRCCS San Raffaele

Recruiting

Registry of Patients With Acute/Subacute Type B Aortic Dissection Treated by Means of the STABILISE Technique (STABILISE) (STABILISE)

Aortic Dissection

United States, Italy, France, Australia, Austria, Brazil, Germany, Netherlands, New Zealand, Portugal, Spain, Sweden, Turkey, United Kingdom
Artivion Inc.
Syneos Health

Recruiting

PERSEVERE- A Trial to Evaluate AMDS in Acute DeBakey Type I Dissection (PERSEVERE)

Acute Aortic Dissection

United States
Endospan Ltd.

Recruiting

NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness (TRIOMPHE)

Aortic Aneurysm | Aortic Dissection | Penetrating Aortic Ulcer | Intramural Hematoma

United States, New Zealand
Bolton Medical

Active, not recruiting

Study of the Relay Pro® Thoracic Stent-Graft in Subjects With Traumatic Injury of the Descending Thoracic Aorta

Other Specified Injury of Thoracic Aorta

United States
Icahn School of Medicine at Mount Sinai

Recruiting

Defining the Basis of Fibromuscular Dysplasia (FMD) (DEFINE)

Spontaneous Coronary Artery Dissection | Fibromuscular Dysplasia | Cervical Artery Dissection

United States
SCAD Alliance
PERFUSE Study Group

Recruiting

International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry

Spontaneous Coronary Artery Dissection

United States, Australia
Ethicon Endo-Surgery

Recruiting

A Study of ECHELON 3000 (Next Generation Powered Stapler) in General Abdominal and Thoracic Lung Resection Procedures

Laparoscopic Sleeve Gastrectomy (LSG) | Thoracic Lung Resection Procedure

United States
Malaghan Institute of Medical Research
Wellington Zhaotai Therapies Limited (WZTL)

Recruiting

ENABLE (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy) (ENABLE)

Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Lymphomas Non-Hodgkin's B-Cell | Transformed Follicular Lymphoma (TFL) | Primary Mediastinal B-cell Lymphoma (PMBCL)

New Zealand
Medtronic Cardiovascular

Completed

Valor II: The Valiant Thoracic Stent Graft System Clinical Study

Thoracic Aortic Aneurysm

United States
Medtronic Cardiovascular
Medtronic

Terminated

Post-Approval Clinical Study of the Talent Thoracic Stent Graft to Treat Thoracic Aortic Aneurysms (THRIVE) (THRIVE)

Thoracic Aortic Aneurysms

United States
GlaxoSmithKline

Completed

Ofatumumab Cardiac Repolarization (QTc) Study in Fludarabine-Refractory Chronic Lymphocytic Leukemia Subjects

Leukaemia, Lymphocytic, Chronic

Australia, United States, New Zealand
Medtronic Cardiovascular
Medtronic

Completed

Study to Determine if the Valiant Stent Graft is Safe and Effective in Treating Patients Who Have a Blunt Thoracic Aortic Injury (RESCUE)

Blunt Thoracic Aortic Injury

United States, Canada
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Completed

National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC)

Marfan Syndrome | Turner Syndrome | Ehlers-Danlos Syndrome | Loeys-Dietz Syndrome | Shprintzen-Goldberg Syndrome | FBN1, TGFBR1, TGFBR2, ACTA2 or MYH11 Genetic Mutation | Bicuspid Aortic Valve Without Known Family History | Bicuspid Aortic Valve With Family History | Bicuspid Aortic Valve With Coarctation and other conditions

United States
Hoffmann-La Roche

Terminated

A Study of Obinutuzumab in Combination With Idasanutlin and Venetoclax in Participants With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) or Rituximab in Combination With Idasanutlin and Venetoclax in Participants With R/R Diffuse Large B-Cell Lymphoma (DLBCL)

Lymphoma, Large B-Cell, Diffuse | Follicular Lymphoma

United States, Australia, Germany, Korea, Republic of, New Zealand
Hoffmann-La Roche

Terminated

A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) Participants

Non-Hodgkin's Lymphoma

United States, Australia, Korea, Republic of, Germany, New Zealand
Memorial Sloan Kettering Cancer Center
Actinium Pharmaceuticals

Recruiting

Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

Diffuse Large B-cell Lymphoma | B-ALL | DLBCL | DLBCL, Nos Genetic Subtypes | B ALL | Dlbcl-Ci | DLBCL Unclassifiable | DLBCL Activated B-Cell Type | DLBCL Germinal Center B-Cell Type | HGBL | HGBL, Nos

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy

B-Cell Lymphoma | B-cell Non Hodgkin Lymphoma | B Cell ALL

United States
ImmunoVaccine Technologies, Inc. (IMV Inc.)
Merck Sharp & Dohme LLC

Recruiting

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (VITALIZE)

Relapsed Diffuse Large B-cell Lymphoma | Refractory Diffuse Large B-cell Lymphoma

Australia, Spain, United States, France, Hungary, New Zealand, Poland, Serbia, Canada, Romania
Memorial Sloan Kettering Cancer Center
Takeda

Recruiting

Study of 19(T2)28z1xx TRAC-Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Lymphoma

B-Cell Lymphoma | Large B-cell Lymphoma | DLBCL, Nos Genetic Subtypes | Mediastinal Large B-cell Lymphoma | High-grade B Cell Lymphoma

United States
Weill Medical College of Cornell University
Bristol-Myers Squibb

Terminated

A Study to Evaluate the Safety and Efficacy of Dasatinib (Sprycel) in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Diffuse Large B-cell Lymphoma

United States
Weill Medical College of Cornell University
Celgene

Completed

Phase I/II Trial of R-CHOP + Azacytidine in Diffuse Large B Cell Lymphoma

Diffuse Large B Cell Lymphoma

United States
Weill Medical College of Cornell University

Completed

Early Response Assessment in Diffuse Large B-Cell Lymphoma (DLCL) Patients by 18-fluoro-2-deoxyglycose Positron Emission Tomography (FDG-PET)

Diffuse Large B-cell Lymphoma

United States
Icahn School of Medicine at Mount Sinai
Bristol-Myers Squibb

Completed

Nivolumab/Ipilimumab-Primed Immunotransplant for DLBCL

Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell Lymphoma

United States
Hackensack Meridian Health
Janssen Scientific Affairs, LLC; Genentech, Inc.

Active, not recruiting

A Study of ABT-199 Plus Ibrutinib and Rituximab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell Lymphoma

United States
Weill Medical College of Cornell University
Epizyme, Inc.; Genentech, Inc.

Recruiting

Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin Lymphoma

Lymphoma, Non-Hodgkin | Follicular Lymphoma | Diffuse Large B Cell Lymphoma

United States
Novartis Pharmaceuticals

Completed

Comparison of Clinical Outcomes Among Patients Treated With Tisagenlecleucel

Diffuse Large B-cell Lymphoma

United States
Novartis Pharmaceuticals

Completed

Real-World HRU and Costs in DLBCL Pts With Tisa-cel and Axi-cel, a Medicare Study.

Diffuse Large B-cell Lymphoma

United States
Novartis Pharmaceuticals

Completed

Real-world Resource Use and Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma (DLBCL): Inpatient and Outpatient Settings

Diffuse Large B-cell Lymphoma

United States
Pharmacyclics LLC.

Completed

Safety and Efficacy Study of a BTK Inhibitor in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Diffuse Large Cell B-lymphoma

United States
National Cancer Institute (NCI)

Completed

Ibrutinib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | CD20 Positive

United States
University of Rochester

Recruiting

A Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell Lymphoma

DLBCL

United States
Memorial Sloan Kettering Cancer Center
Columbia University; Genentech, Inc.

Completed

Therapy for Patients With Untreated Age-Adjusted International Prognostic Index Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B Cell Lymphoma

Non-Hodgkin's Lymphoma

United States
Weill Medical College of Cornell University
Epizyme, Inc.; American Society of Clinical Oncology; Applebaum Foundation

Recruiting

A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas

Follicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-Cell Lymphoma

United States
Novartis Pharmaceuticals

Completed

Real-world Resource Use and Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma (DLBCL)

Diffuse Large B-cell Lymphoma (DLBCL)

United States
Memorial Sloan Kettering Cancer Center

Recruiting

Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers

Lymphoma | Lymphoma, B-Cell | DLBCL - Diffuse Large B Cell Lymphoma | Large B-cell Lymphoma | Large-cell Lymphoma | Mediastinal B-Cell Diffuse Large Cell Lymphoma

United States
Northwell Health

Terminated

Hydroxychloroquine in Untreated B-CLL Patients

B-Cell Chronic Lymphocytic Leukemia

United States

Clinical Trials on Type B Aortic Dissection in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations